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Abstract. The compounds, 7-methyl-3,5-diphenyl-5H-thiazolo[3,2-a]pyrimidine-6-carboxylic acid ethyl
ester (1), 3-amino-2-cyano-7-methyl-5-phenyl-5H-thiazolo[3,2-a]pyrimidine-6-carboxylic acid methyl
ester (2), 2-dimethylaminomethylene-7-methyl-3-oxo-5-phenyl-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidine-
6-carboxylic acid ethyl ester (3), 2-(3-cyano-benzylidene)-5-(4-hydroxy-phenyl)-7-methyl-3-oxo-2,3-
dihydro-5H-thiazolo[3,2-a]pyrimidine-6-carboxylic acid methyl ester; with N,N-dimethyl-formamide (4)
and 3-ethoxycarbonylmethyl-5-(4-hydroxy-3-methoxy-phenyl)-7-methyl-5H-thiazolo[3,2-a]pyrimidine-6-
carboxylic acid methyl ester (5) have been synthesized and their structures evaluated crystallographically.
Compound 1 crystallizes in the space group P ı¯ with Z=8, with four molecules in the asymmetric unit.
Compound 2 also crystallizes in the space group P ı¯ with Z=4 wherein asymmetric unit accommodates two
molecules. Compound 3 belongs to P21/c with Z=4, compound 4 crystallizes in Pbc21 with Z= 4 and
compound 5 belongs to P ı¯ with Z=2. In all the above compounds, the aryl ring positioned at C5 of thiazolopy-
rimidine ring is almost perpendicular. In the case of compounds with substituted phenyl ring, aryl group-up
conformation predominates. However, for compounds with unsubstituted phenyl ring, aryl group-down con-
formation is adopted. By varying the substituents at positions C2, C3, C6 and on the aryl at C5 in the main
molecular scaffold of (1-5), we have observed significant differences in the intermolecular interaction patterns.
The packing features of the compounds are controlled by C-H. . .O, C-H. . .N, N-H. . .N O-H. . .N, C-H. . . π
and π . . . π weak interactions.
Keywords. Thiazolo[3,2-a]pyrimidines; conformational analysis; C-H. . .O, C-H. . .N, N-H. . .N, O-H. . .N,
C-H. . . π and π . . . π weak interactions.
1. Introduction
Thiazolo[3,2-a]pyrimidine derivatives are potential
bioactive molecules. These have been of interest
due to their anti-microbial,1 –5 anti-inflammatory6 and
anti-hypertensive activities. Thiazolo[3,2-a]pyrimidine
compounds have interesting biological potentialities,
particularly as inotropic agents and novel therapeu-
tically active entities for severe neurodegenerative
diseases.7 In addition, thiazolo[3,2-a]pyrimidine deri-
vatives have shown significant anti-malarial and HIV-
RT inhibitory activities. Recently, a new series of thia-
zolo[3,2-a]pyrimidines have been identified to exhibit
anti-inflammatory and anti-nociceptive activities.8
In view of the tremendous application of this class of
compounds, we have substituted different substituents
on the thiazolopyrimidine ring at various positions.
One of the objectives of these structure determinations
was to investigate how the introduction of different
∗For correspondence
substituents influences the supramolecular aggrega-
tions. We have recently reported a number of crystal
structures of thiazolo[3,2-a]pyrimidine derivatives with
various substituents.9a-c In the present work we have
investigated the role of functional groups on molecular
geometry, conformation and generation of supramolec-
ular assemblies in the solid state. In this regard,
the understanding of molecular recognition processes
enables a better understanding of the physical and
chemical properties of the solid. It is a cooperative
interplay amongst both strong hydrogen bonds and
weak intermolecular interactions which dictate overall
packing in the crystal lattice.
2. Experimental
2.1 Synthesis
Syntheses of compounds 1-5 is given in scheme 1.
The compound 1 was synthesized according to the
reported procedure7 by treating 6-methyl-4-phenyl-
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Scheme 1. Synthesis of various thiazolopyrimidines.
2-thioxo-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic
acid ethyl ester with phenacyl-bromide in equimolar
quantities. Compound 2 was prepared by react-
ing 6-methyl-4-phenyl-2-thioxo-1,2,3,4-tetrahydro-
pyrimidine-5-carboxylic acid methyl ester with mono-
bromo malanonitrile using strong base under warm
condition.10 Compound 3 was obtained by reflux-
ing 6-methyl-4-phenyl-2-thioxo-1,2,3,4-tetrahydro-
pyrimidine-5-carboxylic acid ethyl ester with
dimethylformamide-dimethylacetal. Compound 4 was
synthesized according to the procedure described9a,11
by treating 4-(4-hydroxy-phenyl)-6-methyl-2-thioxo-
1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid methyl
ester with chloro-acetic acid and 3-cyano benzaldehyde
in presence of sodium acetate. Synthesis of compound
5 was followed by the method reported earlier.3
2.2 X-ray diffraction analysis
Single crystals of compounds 1-5 were obtained by
slow evaporation from a solution using ethylacetate,
DMF and ethanol solvents for compounds 1-2, 3-4 and
5 respectively
A good single crystal in each case was mounted along
its largest dimension and used for data collection. The
intensity data were collected on a Bruker Smart CCD
Area Detector System using MoKα (0.71073Å) radi-
ation in ω −  scan mode. The data were reduced
using SAINT-Plus.12 The structure in each case was
solved by Direct Methods and refined on F2 using
SHELX-9713 package. All the non-hydrogen atoms
were refined anisotropically. As the hydrogens were
not readily revealed from difference Fourier maps,
they were included in the ideal positions with fixed
isotropic U values, and they were riding with their
respective non-hydrogen atoms. The difference Fourier
map, after the refinement, was essentially featureless
in all cases.The mean plane calculations were done
using the program PARST.14 Diagrams and publication
material were generated using ORTEP-3,15 PLATON,16
CAMERON17 and DIAMOND.18
3. Results and Discussion
3.1 Crystallography
Summary of crystallographic data and other structure
refinement parameters of the compounds 1-5 are given
in table 1. Table 2 gives hydrogen bond parameters
in compounds 1-5. Table 3 gives the conformational
parameters. The ORTEP view of the molecules 1-5 with
atomic labeling (thermal ellipsoids drawn at 50% prob-
ability) is shown in figure 1. Figures 2 and 3 show
C-H. . .O and C-H. . .N intermolecular interactions in
compound 1. Packing of molecules for compounds 2-5
are shown in figures 4–7 respectively.
Compounds 1, 2 and 5 crystallize in the triclinic
crystal system with four, two and one molecule in the
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Table 1. Crystal data and refinement parameters for 15.
1 2 3
Formula C22H20N2O2S C16H14N4O2S C19H21N3O3S
M 376.47 326.37 371.45
T /K 100(2) 100(2) 100(2)
Crystal size/mm3 0.18x0.16x0.16 0.18x0.16x0.16 0.18x0.16x0.16
Crystal system Triclinic Triclinic Monoclinic
Space group P ı¯ P ı¯ P21/c
a/Å´ 10.2794(5) 9.7071(13) 8.6855(6)
b/Å´ 19.4444(9) 13.7486(19) 23.4318(16)
c/Å´ 20.9903(11) 13.8865(19) 8.9230(6)
α/(◦) 101.731(3) 118.761(2) 90
β/(◦) 103.305(3) 91.352(2) 104.665(1)
γ /(◦) 90.032(4) 100.936(2) 90
V/Å´
3
3992.6(3) 1580.9(4) 1756.8(2)
Z, dcalcd/( g cm−3) 8, 1.253 4, 1.371 4, 1.404
μ/mm−1 0.18 0.22 0.21
F (000) 1354 680 784
θ range/(◦) 1.32−27.00 1.69−27.00 1.74−25.00
Index ranges −13 ≤ h ≤ 12 −12 ≤ h ≤ 12 10 ≤ h ≤ 10
−24 ≤ k ≤ 24 −17 ≤ k ≤ 15 27 ≤ k ≤ 18
−26 ≤ l ≤ 26 17 ≤ l ≤ 16 −1 ≤ l ≤ 1
Reflections collected 67809 9727 9041
Independent 17367 6712 3085
reflections [Rint = 0.076] [Rint = 0.0333] [Rint = 0.0219]
Completeness 99.7% 971% 99.6%
Data/restraints/parameters 17367/0/982 6712/0/419 3085/0/239
Goodness-of-fit onF 2 1.118 0.985 0.998
R1, wR2[I > 2σ(I)] 0.086, 0.2160 0.081, 0.2164 0.039, 0.1104
R1, wR2(all data) 0.1960, 0.2431 0.1294, 0.2947 0.0427, 0.1154
Largest diff. peak, hole/(e A−3) 0.853, −0.383 1.079, −0.725 0.400, −0.299
4 5
Formula C26H24N4O5S C20H22N2O6S
M 504.55 418.46
T /K 100(2) 100(2)
Crystal size/mm3 0.18x0.16x0.16 0.18x0.16x0.16
Crystal system Orthorhombic Triclinic
Space group P ca21 P ı¯
a/Å´ 12.298 7.0811(11)
b/Å´ 13.680 8.2731(13)
c/Å´ 14.540 17.244(3)
α/(◦) 90 80.942(2)
β/(◦) 90 81.340(2)
γ /(◦) 90 83.065(3)
V/Å´
3
2446.2 981.3(3)
Z, dcalcd/(g cm−3) 4, 1.370 2, 1.416
μ/mm−1 0.178 0.206
F (000) 1056 440
θ range/(◦) 2.23−25.00 2.41−27.00
Index ranges −14 ≤ h ≤ 14 −9 ≤ h ≤ 8
−13 ≤ k ≤ 16 −9 ≤ k ≤ 1
−15 ≤ l ≤ 17 −21 ≤ l ≤ 18
Reflections collected 12107 5793
Independent 4152 4103
reflections [Rint = 0.0638] [Rint = 0.0219]
Completeness 100.0 % 962%
Data/restraints/parameters 4152/1/333 4103/0/279
Goodness-of-fit onF 2 1024 1.458
R1, wR2[I > 2σ(I)] 0.0653, 0.1496 0.074, 0.2062
R1, wR2(all data) 0.0969, 0.1702 0.1027, 0.2838
Largest diff. peak, hole/(e A−3) 0.357, −0.238 0.788, −0.947
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Table 2. Non-bonded interactions and possible hydrogen bonds (Å,◦) for compounds 1-5 (D-donor; A-acceptor; H-
hydrogen).
D—H· · · A D—H H· · · A D· · · A D—H· · · A
Compound 1
C2c -H2c. . .O2ci 0.930 2.330 3.223 (6) 161
C2d -H2d. . .O2dii 0.930 2.356 3.241 (6) 159
C18c -C18c. . .O2ciii 0.930 2.455 3.384 (5) 177
C18d –H18d. . .O2div 0.930 2.448 3.377 (4) 176
C8c-H8c. . .Cg1v 0.970 2.951 3.728(6) 144
C8d-H8d. . .Cg2vi 0.970 2.932 3.774(5) 146
C13a-H13a. . .Cg3vii 0.930 3.086 3.896(2) 147
Symmetry code: ( i) x+1,+y,+z (ii) x-1,+y,+z (iii) -x+1,-y+1,-z (iv) -x+1,-y+2,-z
(v) -x,+y-1/2,+z (vi) 1-x,2-y,-z (vii) 1-x, 1-y, -0.5+z
Compound 2
N3a-H3a1. . .N2b i 0.860 2.086 2.809 (7) 141
N3b-H3b1. . .N2aii 0.860 2.051 2.839 (6) 152
N3b-H3b2. . .N4aiii 0.930 2.303 3.035 (7) 143
C13a -H13a. . .O1biv 0.930 2.666 3.457 (7) 143
Symmetry code: ( i) -x+1,-y+2,-z-1 (ii) -x+1,-y+2,-z (iii) x+1,+y,+z (iv) x-1,+y+1,+z+1
Compound 3
C17-H17. . .O1 i 0.930 2.319 3.226 (2) 165
C18-H18a. . .O1 i 0.960 2.475 3.380 (2) 157
C14-H14. . .O2ii 0.960 2.651 3.453 (2) 141
Symmetry code: ( i) -x,-y+1,-z+2 (ii) x+1,+y,+z
Compound 4
C4-H4a. . .O5 i 0.960 2.595 3.550 (5) 173
C13-H13. . .N3ii 0.930 2.498 3.223(3) 134
C22-H22. . .O2iii 0.930 2.219 3.045 (5) 147
C16-H16. . .O2iii 0.930 2.359 3.198(5) 150
C18-H18. . .O1iv 0.930 2.309 3.091(6) 141
C20-H20. . .N2v 0.930 2.411 3.168(5) 138
C25-H25C. . .CgVii 0.960 3.020 3.957(3) 143
Symmetry code: ( i) -x-1/2,+y,+z+1/2, (ii) -x,-y+2,+z+1/2, (iii) -x,-y+2,+z-1/2,
(iv) x+1/2,-y+2,+z, (v) -x+1,-y+2,+z-1/2, (vi) -1/2-x,y,1/2+z
Compound 5
O6-H6. . .N2i 0.820(3) 2.081(3) 2.882(4) 165
C16-H16C. . .O3ii 0.960(3) 2.521 (2) 3.401 (3) 152
C12-H12. . .Cgiii1 0.960(2) 3.120 (3) 3.977(5) 153
Symmetry code: ( i) -x+1,-y+1,-z+1 (ii) -x,-y+1,-z (iii) 1-x, 1-y, 1-z
asymmetric unit respectively, whereas the compound 3
crystallizes in the monoclinic crystal system with one
molecule in the asymmetric unit, compound 4 crystal-
lizes in the orthorhombic crystal system along with a
DMF solvent molecule. In all the compounds (1-5),
the thiazolopyrimidine ring has almost similar sub-
stituent such as aryl, carboxylate and methyl groups
at C5, C6 and C7 positions respectively. We have
substituted nitrile, dimethyl-vinyl-amine and 3-cyano-
benzylidene groups at C2 position in compounds 2, 3
and 4 respectively. The position C3 has different sub-
stituents such as, phenyl, amine, oxo, oxo and ethyl
carboxylate groups in compounds 1-5 respectively. The
fused thiazole ring is essentially planar with a r.m.s
deviation for compounds 1-5 being 0.0078 Å´, 0.0093
Å´, 0.0169 Å´, 0.0167 Å´ and 0.0091 Å´ respectively. The
central pyrimidine ring in compounds 2, 3, 4 and 5
adopts a twist boat conformation due to the deviation of
atoms C5 and N2 from the mean plane C6/C7/C9/N1
constituting the ring by -0.230(5)/0.094(4), 0.367(1)/
-0.084(1), 0.253(5)/-0.105(4) and 0.55(4)/0.033(3) Å´,
respectively.9b,19 The ring puckering parameters20 for
the pyrimidine ring of compound 2 are Q(T) =
0.2113(4)/0.177(4)Å´, ϕ(2)◦ = −18.53(1)/ − 5.32(2)
and θ(2)◦ = 118.48(1)/125.07(2) the two values
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Table 3. Conformational parameters of thiazolopyrimidines.
Compound Different substituent at Orientation of the aryl Deviating atoms Dihedral angle
code C2 C3 C5 C6 group w.r.t. C5-H5 / from the mean between the aryl
Plane of thiazolopy- plane of thiazo- and pyrimidine/
rimidine lopyrimidine thiazolopyri-
midine ring
1 H Ph Ph CO2Et Synperipl-anar /both Only C5 82.80
2 CN NH2 Ph CO2Me Antiperipl-anar / C5 and N2 88.12
Aryl down
3 =CHNMe2 =O Ph CO2Et Antiperipl-anar / C5 and N2 84.00
Aryl down
4 3-Cyano =O 4-OH-Ph CO2Me Synperipl-anar / C5 and N2 87.56
benzylidene Aryl up
5 H CH2CO2Et 4-OH, CO2Me Synperipl-anar / C5 and N2 81.00
3-OCH3-Ph Aryl up
separated by ‘/’ correspond to the two molecules 2a
and 2b in the asymmetric unit. The ring puckering
parameters for the pyrimidine ring of compound 3 are
Q(T) = 0.3084(2)Å´, ϕ(2) = −14.06(2)◦ and θ(2) =
69.33(1)◦ , the ring puckering parameters for the pyrim-
idine ring of compound 4 are Q(T) = 0.2369(5)Å´,
ϕ(2) = 160.75(1)◦ and θ(2) = 112.44(1)◦ and
for compound 5 are Q(T) = 0.0578 (4)Å´, ϕ(2) =
155.69(4)◦ and θ(2) = 112.96(1)◦ . In compounds 2-
5, we have observed deviation of C5 and N2 from
the mean plane, which is a common feature observed
in all thiazolopyrimidine structures. However, we have
observed an unusual feature in the case of compound
1 where only C5 chiral carbon atom is significantly
puckered and adopts half chair conformation with C5
atom being deviated by 0.149(4) Å´. The ring pucker-
ing parameters for the pyrimidine ring of compound 1
are Q(T)= 0.2737(3)/0.2815(3)/0.1977(4)/0.208(4) Å´,
ϕ(2)◦ = −7.99(8)/172.41(8)/ − 15.87(2)/163.49(1)
and θ(2)◦ = 114.69(7)/68.75(7)/118.39(1)/64.13(1)
the four values separated by ‘/’ correspond to the four
molecules 1(a-d) in the asymmetric unit.
In compounds 3, 4 and 5, the aryl ring is positioned in
such a way that there are C-H. . . π (arene) intramolecu-
lar interactions. However, in compounds 1 and 2 the aryl
ring almost bisects the pyrimidine ring. The orientation
of the phenyl group at C5 is evidenced from the absence
of intramolecular C-H. . . π interaction. The carboxy-
late group at C6 adopts cis conformation with respect
to C6=C7 bond in compounds 1, 2, 3 and 5 because of
intramolecular hydrogen bond between carbonyl group
of ester and methyl substituent at C7, whereas in com-
pound 4 it adopts trans conformation. In compound 5,
the ethyl carboxylate group at C17 is almost parallel
to the aryl ring with dihedral angle of 12.16◦ due to
intramolecular carbonyl. . . π interaction21 between the
ethyl carboxylate and aryl ring, a similar feature was
observed in another derivative reported earlier.9b
The intermolecular interaction of compound 1 is
quite complicated since there are four molecules in the
asymmetric unit. The four molecules of compound 1 are
linked through C2d-H2d. . .O2d and C22d-H22d. . .O2d
interactions resulting in the sheet like structure run-
ning along crystallographic ‘a’ axis (figure 2). The
molecules 1c & 1d which are interconnected through
C12c-H12c. . .N2d, and C12d-H12d. . .N2c forms cen-
trosymmetric head to head dimers with graph set22
motif R22(14) along ‘c’ axis, in one case N2d is the
acceptor and in the other case it is N2c. In addi-
tion, C18d-H18d. . .O2c interaction links with the above
two interactions to form centrosymmetric head to head
dimers with graph set motif R22(18). The above three
interactions of the molecules 1c & 1d leads to a paral-
lel arrangement of molecules in a zigzag manner along
‘b’ axis (figure 3). The other two molecules 1a & 1b
within the unit cell are arranged in syndiotactic manner
along ‘b’ axis without any strong intermolecular inter-
action. In addition to these interactions, the molecules
1c & 1d are linked into dimers by two C-H. . .Cg inter-
actions (table 2); atoms C8c and C8d in the molecule
act as donor, via H8c2 and H8d2 atoms respectively,
to the thiazolopyrimidine ring. The additional C13a-
H13a. . .Cg (centroid of the C11c-C16c ring) interaction
is also observed between molecules 1a & 1c.
The crystal structure of compound 2 is stabi-
lized by intermolecular N-H. . .N and C-H. . .O inter-
actions. There are three types of N-H. . .N interac-
tions, in which two interactions N3a-H3a1. . .N2b, and
N3b-H3b2. . .N4a result in sheet like structure. These
sheets are further connected through N3b-H3b. . .N2b
interactions. The C13a-H13a. . .O1b interaction bridges
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1(a-d) 2a & 2b
3                                                                                4
5
Figure 1. ORTEP view of compounds 1-5 with four, two, one, one and one molecule in the asymmetric unit respectively,
showing 50% probability ellipsoids and the atom numbering scheme.
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Figure 2. Packing of the molecules of compound 1 showing C-H. . .O intermolecular
interactions along ‘a’ axis.
Figure 3. Formation of molecular dimers by C-H. . .O and C-H. . .N inter-
molecular interactions along ‘b’ axis in compound 1.
Figure 4. Packing diagram of compound 2 showing, C-H. . .O and N-H. . .N
hydrogen bonds.
1354 H Nagarajaiah and Noor Shahina Begum
the above set of interaction. The molecular pack-
ing of compound 2 is further stabilized by π . . . π
stacking interactions between the thiazolopyrimidine
Figure 5. Dimers formed by C-H. . .O contacts in com-
pound 3.
rings with the interplanar distances between the two
rings being 3.447 Å. In comparison to compounds 1 and
2, compound 3 has no C-H. . .N and N-H. . .N inter-
action. In compound 3 the molecular arrangement is
consolidated by C-H. . .O type intermolecular interac-
tions, involving carbonyl O1 forming centrosymmetric
dimers with graph set notation R22(10) and R21(6) along
‘a’ axis. The other C14-H14. . .O2 interaction connects
the molecules into two dimensional network.
In compound 4, the molecules are linked by two
types of C-H. . .N interactions, i.e., C20-H20. . .N2 and
C13-H13. . .N3. In the former interaction C20 (0.5+x,
2-y, z) acts as a hydrogen donor to the N2 (1.5-x, y,
-0.5+z) atom of pyrimidine generating two dimen-
sional sheets along ‘a’ axis, whereas in the later interac-
tion C13 (0.5-x, y, 0.5+z) acts as a donor to N3 (0.5+x,
2-y, 1+z) of the nitrile group generating helical pattern
running along ‘c’ axis. As in compound 1, it exhibits
two types of C-H. . .O interactions, the former gener-
ates bifurcated bonds from two donors, C16 and C14,
to the same acceptor O2 along ‘a’ axis and the lat-
ter C4-H4. . .O5 forms the zig-zag chain running along
‘c’ axis. C-H. . .Cg (Cg is the centroid of phenyl ring
C11/C12/C13/C14/C15/C16) at a distance of 3.020 Å´
is also observed (table 2). In compound 5, C-H. . .N
interaction is absent; instead molecules are linked into
Figure 6. Crystal packing of compound 4 held by a network of C-H. . .O and
C-H. . .N interactions forming a three dimensional helical pattern.
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Figure 7. Packing of molecules via C-H. . .O and O-H. . .N
interactions in compound 5.
one dimensional chain through O6-H6. . .N2 interaction
along ‘b’ axis. The C16-H16. . .O3 interaction, wherein,
the C-H of the methoxy on aryl ring and carboxylate O
at C3 of the thiazolopyrimidine forms centrosymmetric
head to head dimers with graph set motif R22(20) along
‘c’ axis resulting in the same pattern as that observed
for compound 4. As in compounds 1 and 4, the pack-
ing in compound 5 is further stabilized by C-H. . .Cg
interaction between the aryl hydrogen and thiazole ring
(table 2).
The five compounds discussed in this work pos-
sess most structural aspects, if not all, of the classical
dihydropyrimidines which predispose them to excellent
receptor-binding prospects. From the above conforma-
tional features it can be inferred that all of them have
exploitable potential to function as calcium channel
blockers.23–25
4. Conclusion
In this work, we have analyzed different thiazolopy-
rimidine derivatives by varying the substituents on the
thiazolopyrimidine ring. With respect to weak inter-
actions, it can be inferred that by changing the sub-
stituents at C2, C3, C6 and the substituent on the aryl
ring at C5 of the thiazolopyrimidine, there is substan-
tial alteration in the mode of intermolecular interac-
tions. With regard to their supramolecular assemblies,
all of them show a remarkable propensity to form
dimers, often centrosymmetric and head-to-head ones
involving C-H. . .O bonds. Apart from this, their crystal
structures are rendered cohesive by intermolecular
C-H. . .N, O-H. . .N and N-H. . .N hydrogen bonds.
Apart from the above, there is novel coexistence
of intramolecular carbonyl. . . π in compound 5. In
addition, C-H. . . π and π . . . π interactions are also
observed.
Supplementary Information
The CIF files are deposited at the Cambridge Crys-
tallographic Data Centre, The deposition numbers for
compounds 1-5 are CCDC-917410, CCDC-942734,
CCDC-942735, CCDC-997509 and CCDC-917409
respectively. These data can be obtained free of charge
at www.ccdc.cam.ac.ul/conts/retrieving.html [or from
the Cambridge Crystallographic Data Centre (CCDC),
12 Union Road, Cambridge CB2 1EZ, UK; fax:
+44(0)1223-336033; email: deposit@ccdc.cam.ac.uk].
Acknowledgement
N S B acknowledges the financial support by University
Grants Commission (UGC), New Delhi, under the
major research project [F-No-37-86/2009(SR)]. H N
thanks UGC for the fellowship.
References
1. El-Emary T I and Abdel-Mohsen S A 2006 Phosphorus,
Sulfur Silicon Relat. Elem. 181 2459
2. Mohamed S K Y, Ragaa A A, Mohamed S A, Shawkat
A A and Ahmed A O 2008 Monatsh Chem. 139 553
3. Nagarajaiah H, Khazi I M and Begum N S 2012
J. Chem. Sci. 124 847
4. Sayed H H, Morsy E M H and Kotb E R 2010 Syn. Com.
40 2712
5. Yaragatti N B, Kulkarni M V, Ghate M D, Hebbar S S
and Hegde G R 2010 J. Sulfur Chem. 31 123
6. Abu-Hashem A A, Gouda M A and Badria F A 2010
Eur. J. Med. Chem. 45 1976
7. Hui Z, Lan-mei C, Lin-lin Z, Si-jie L, David C C W,
Huang-quan L and Chun H 2008 ARKIVOC. 8 266
8. Ozair A, Suroor A K, Nadeem S and Waquar A 2010
Med. Chem. Res. 19 1245
9. a) Nagarajaiah H, Fathima N and Begum N S 2012 Acta
Cryst. E 68 o1257; b) Nagarajaiah H and Begum N S
2012 Acta Cryst. E 68 o2878; c) Nagarajaiah H and
Begum N S 2011 Acta Crystallogr. E 67 o3444
10. Mobinikhaledi A and Foroughifar N 2004 Phosphorus,
Sulfur Silicon Relat. Elem. 179 1175
11. Singh S, Schober A, Gebinoga M and Alexander G G
2011 Tetrahedron. 52 3814
12. Bruker, SMART, SAINT-Plus, SADABS. Bruker Axs
Inc. 1998 Madison, Wisconcin, USA
1356 H Nagarajaiah and Noor Shahina Begum
13. Sheldrick G M 2008 Acta Cryst. A 64 112
14. Nardelli M 1983 Acta Cryst. C 39 1141
15. Farrugia L J 1997 J. Appl. Cryst. 30 565
16. Spek A L 2009 Acta Cryst. D 65 148
17. Watkin D J, Prout C K and Pearce L J 1996 CAMERON.
Chemical Crystallography Laboratory, University of
Oxford, England
18. Brandenburg K and Putz H 2005 Crystal Impact. GbR,
Bonn, Germany
19. Mukesh M J, Bharat B B and Jerry P J 2010 Acta Cryst.
E 66 o599
20. Cremer D and Pople J A 1975 J. Am. Chem. Soc. 97 1354
21. Gautrot J E, Hodge P, Cupertino D and Helliwell M
2006 New J. Chem. 30 1801
22. Bernstein J, Davis R E, Shimoni L and Chang N L 1995
Angew. Chem. Int. Ed. Engl. 34 1555
23. Kappe C O 1998 Molecules 3 1
24. Rovnyak G C, Kimball S D, Beyer B, Cucinotta G,
DiMarco J D, Gougoutas J Z, Hedberg A, Malley M,
McCarthy J P, Zhang R and Moreland S 1995 J. Med.
Chem. 38 119
25. Kappe C O 2000 Eur. J. Med. Chem. 35 1043
